Yuju Ma

Statistics

Publications

Citations

2.3K

H-Index

Active since

2005

Affiliations

Teva Pharmaceuticals (United States)(Current)

Thomas Jefferson University

Albert Einstein College of Medicine

Mayo Clinic Hospital

Wellcome Trust

Yuju Ma is an author at Teva Pharmaceuticals (United States) specializing in headache disorders, preventive migraine therapy, and clinical pharmacology.

Publications per year

2005–2021

Publications

Fremanezumab for the Preventive Treatment of Chronic Migraine

Stephen D. Silberstein, David W. Dodick, Marcelo E. Bigal et al. · New England Journal of Medicine · 2017 · 803 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine

David W. Dodick, Stephen D. Silberstein, Marcelo E. Bigal et al. · JAMA · 2018 · 573 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study

Marcelo E. Bigal, David W. Dodick, Alan M. Rapoport et al. · The Lancet Neurology · 2015 · 285 citations

Medicine, Neurology, Preventive Medicine +8

Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study

Marcelo E. Bigal, Lars Edvinsson, Alan M. Rapoport et al. · The Lancet Neurology · 2015 · 260 citations

Medicine, Neurology, Preventive Medicine +9

Alvimopan: An oral, peripherally acting, μ-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction—A 21-day treatment-randomized clinical trial

Daniel M. Paulson, Daniel Kennedy, Roger A. Donovick et al. · Journal of Pain · 2005 · 157 citations

Medicine, Pharmacology, Pharmacotherapy +16

1–5 of 11